Belgium vs Israel: Diphtheria tetanus toxoid and pertussis third-dose (DTP3)
Belgium
98.0%
in 2025
Israel
98.0%
in 2025
Belgium rank
20th
Israel rank
20th
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) over time
- Belgium
- Israel
How they compare
Belgium currently reports 98.0% against 98.0% in Israel, a difference of 0.0%.
The two have swapped places 3 times across 26 shared years of data; in 2000 it was Belgium ahead.
Belgium ranks 20th and Israel ranks 20th of 194 countries.
Across the 3 decades both report, Belgium averaged higher in 2 and Israel in 1.
Head to head by decade
| Decade | Belgium | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 96.5% | 93.6% | 2.9% | Belgium |
| 2010s | 98.3% | 95.7% | 2.6% | Belgium |
| 2020s | 97.8% | 98.0% | 0.2% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher diphtheria tetanus toxoid and pertussis third-dose (dtp3), Belgium or Israel?
- Belgium, at 98.0% against 98.0% in Israel as of 2025.
- What is the difference in diphtheria tetanus toxoid and pertussis third-dose (dtp3) between Belgium and Israel?
- 0.0%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Israel?
- 26 years are reported by both, from 2000 to 2025.
- How do Belgium and Israel rank globally for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- Belgium ranks 20th and Israel ranks 20th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.